[Prevention of bronchopulmonary inflammation in patients with lung cancer receiving cytostatic therapy].
Viazitskiĭ
P O
PO
Iakovlev
V N
VN
Alekseev
V G
VG
Dmitriev
Iu K
IuK
Duganov
V K
VK
D015250:Aclarubicin / Q000008:administration & dosage; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D001996:Bronchopneumonia / Q000209:etiology / Q000517:prevention & control*; D018288:Carcinoma, Small Cell / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D002294:Carcinoma, Squamous Cell / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D002945:Cisplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D008168:Lung / Q000187:drug effects / Q000276:immunology; D008175:Lung Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D017663:Peplomycin; D014750:Vincristine / Q000008:administration & dosage
D001761:Bleomycin; D017663:Peplomycin; D014750:Vincristine; D015250:Aclarubicin; D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin; D008727:Methotrexate
Profilaktika bronkholegochnykh vospaleniĭ u bol'nykh rakom legkogo, poluchavshikh tsitostaticheskuiu terapiiu.